# Best Pharma CRM for Sales Reps and Managers, Compared by Job

https://salesbond.app/blog/best-pharma-crm-sales-reps-compared-by-job/
Published: 2026-11-06 · Updated: 2026-11-12

A pharma CRM is the system a pharma sales team uses to plan and log visits to healthcare professionals (HCPs), keep consent and approved materials on the doctor’s record, and show the manager how much of each territory was covered this month. Field reps who carry samples to prescribers usually end up on an industry platform such as Veeva Vault CRM or Salesforce Life Sciences Cloud, which ships that model out of the box. A specialty team that sells to pharmacies, wholesalers and clinics without samples is usually fine on a general CRM such as HubSpot, Zoho CRM or Pipedrive, once you build the visit model yourself.

Which path fits depends on the size of the field force and how much regulated work you plan to keep inside the CRM. Both can be checked on a demo in under an hour, with your own territory list.

## Quick answer: which CRM fits your pharma or specialty sales team

Most “pharma CRM” pages are either a vendor’s own list or a glossary. Neither tells a sales director with twelve reps and a product launch in March what to buy. Start from the job instead.

For field reps calling on prescribers, the shortlist is Veeva Vault CRM, Salesforce Life Sciences Cloud, or Microsoft Dynamics 365 in a life-sciences build. On the demo, ask for one HCP record with the visit history, the consent status and the materials shown, all on one screen.

For a specialty, generics or OTC team without samples, the shortlist is HubSpot, Zoho CRM or Pipedrive configured for visits. What you want to see is a visit saved as its own activity type, with outcome and next-visit date on the account.

Key account managers working hospitals and tenders, with a handful of reps in the field, are the awkward middle. Put the tender pipeline in a general CRM first and test visit logging there before adding a second system. The demo should show the tender as a deal with stages and the hospital visit on the same account record.

The two expensive mistakes run in opposite directions. A six-person team buys a platform built for a thousand reps and spends the first year configuring it. An eighty-rep field force with samples in the trunk runs on a general CRM and ends up with consent in a spreadsheet and sample receipts in a photo folder. Both would have caught it on a demo.

## What a rep needs by Friday and a manager needs by Monday

A medical rep’s week is a list of doctors, sorted by how much each one matters to the plan. Tier A gets seen every two weeks, tier B monthly, tier C when the route allows. The CRM’s first job is to hold that list with tier, specialty, practice address and last visit date, and turn it into a route for Monday morning. If planning a week means exporting to a spreadsheet, the plan lives in the spreadsheet and the CRM becomes a diary nobody reads.

The second job is the visit. In pharma it is called detailing: the rep walks a doctor through a product, its indications and the evidence behind it, using materials the company has already approved. That approval usually goes through MLR review (medical, legal, regulatory), so the rep can’t improvise a slide. What gets logged after a nine-minute conversation in a corridor is short: who, which product was detailed, which approved material was shown, what the doctor said, when the next visit is. A rep will log that from the car if it takes under a minute and skip it if it takes five.

Consent sits here too. Did this HCP agree to receive email or messages, on which date, through which channel? The follow-up depends on it, so the field belongs on the record, where it outlives the rep’s memory.

The manager’s job is coverage. Of the two hundred target HCPs in a territory, how many were visited this month, how many tier-A doctors have gone more than thirty days without a visit, how many visits have no note and no next date. A field manager in any industry asks the same, and the mechanics of visit logging and the Monday review are in [field sales in the CRM: how a manager sees what reps did on the road](https://salesbond.app/blog/field-sales-visit-logging-crm/). Pharma adds the tiering, the consent and, where samples are involved, a receipt the doctor signs. That receipt is the line between the two classes of software. If your process includes it, ask every vendor to show it, and don’t assume it is there because the website says “life sciences”.

![Two-column job map: what a rep keeps on the HCP record by Friday, linked by arrows to what a manager reads by Monday](https://salesbond.app/wp-content/uploads/2026/11/best-pharma-crm-sales-reps-compared-by-job-2.png)

## Industry platforms: what the vendors say, and the question that follows

Veeva’s current product is Vault CRM (as of November 2026, per its product page). Veeva announced in April 2024 that it is the go-forward option for new customers, with teams on the older Veeva CRM being moved to it ( [Veeva announcement](https://www.veeva.com/resources/veeva-vault-crm-now-available-for-all-new-customers/)), so you will hear both names in the same meeting. Veeva describes it as an “agentic CRM for life sciences that connects sales, marketing, and medical teams on a single platform with a unified customer database and embedded AI” ( [Veeva Vault CRM](https://www.veeva.com/products/crm/)). Salesforce sells Life Sciences Cloud and says its life sciences software is “built for pharmaceutical and medical technology companies” ( [Salesforce Life Sciences](https://www.salesforce.com/life-sciences/)). Microsoft Dynamics 365 is the third name in this class, normally through a partner’s life-sciences configuration.

Read those two quoted lines again. They say “life sciences” and “pharmaceutical”. They don’t say “visit”, “sample” or “consent”, so those three have to come from the demo. Ask for the HCP record, then a visit logged on it, then the consent captured, then a sample receipt signed, then the manager’s coverage view for one territory. Five screens, and no detour into “that’s a module we would scope later”.

For a team under ten reps we’d add one more question before anyone talks price: who configures it, and how long until the first territory goes live? The value of an industry platform is that the pharma model is already there. The cost is that the model is big, and a small team pays for all of it.

## General CRMs: the pharma layer you build yourself

In HubSpot, Zoho CRM or Pipedrive nobody has heard of an HCP. You have a contact, a company or organization, a deal and an activity, and the pharma layer is whatever you put on top. For a team without samples that layer is small, and you own it.

The contact is the doctor, with custom fields for specialty, tier and target segment. The organization is the practice, pharmacy or hospital. The visit is an activity type of its own, not a generic “call”, so the manager can count visits separately from phone calls; add fields for the product detailed, the material shown and the outcome. The next visit is the next activity with a date, created before the rep leaves the parking lot. Consent is a field on the contact with a date and a channel, plus the rule that marketing emails go only to contacts where that field says yes. The territory is the owner plus a region field. The coverage report is just a filter: contacts in this territory, tier A, last visit more than thirty days ago.

A setup like that carries a specialty or OTC team a long way. It leaves out the regulated work of sample inventory with signed receipts, versioned approved content with proof of what was shown, and a change history that holds up in an audit, so ask about those explicitly. On a general CRM the honest answer is often “through an add-on” or “not in the CRM”, and you want to decide whether that is acceptable before you configure anything.

Which general CRM fits the rest of the company is covered in [best CRM for your type of business](https://salesbond.app/blog/best-crm-software-by-business-type/). If the team sells to clinics and practices rather than to prescribers, the healthcare side of the same choice is in [best healthcare CRM for clinics and practices, compared by job](https://salesbond.app/blog/best-healthcare-crm-clinics-practices-compared-by-job/).

## 21 CFR Part 11: what to ask the vendor, and what not to promise

21 CFR Part 11 is the FDA regulation on electronic records and electronic signatures. Whether a given visit log or sample receipt in your CRM falls under it is a question for your quality and compliance people.

FDA’s guidance on the scope of the rule is worth reading before that conversation. It says the agency “will narrowly interpret the scope of part 11” and intends to “exercise enforcement discretion with respect to certain part 11 requirements”, naming “the validation, audit trail, record retention, and record copying requirements”. It also says that “records must still be maintained or submitted in accordance with the underlying predicate rules” ( [FDA, Part 11 Scope and Application guidance, September 2003](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application)). We are not going to turn that into legal advice, and a CRM vendor’s sales team shouldn’t either.

What a buyer can do is ask plain questions about the things the guidance names. It refers to “computer-generated, time-stamped audit trails”, so ask whether the system keeps a time-stamped history of changes to a visit record, with the earlier value still visible, and whether that history can be exported. If a doctor signs for a sample on the rep’s tablet, what does the signed record show: who signed, when, and what the signature was for? Is there validation documentation, and who maintains it when the vendor ships an update?

Notice who the guidance talks to: it says “persons must still comply with all applicable predicate rule requirements”. Companies and people. So when a vendor says “Part 11 compliant”, ask which of those requirements still sit with your own procedures around the system.

## The demo test, run with your own territory list

![One-page demo card with five tests for a pharma CRM vendor call, each with Pass and Fail boxes and a note line](https://salesbond.app/wp-content/uploads/2026/11/best-pharma-crm-sales-reps-compared-by-job-3.png)

Bring twenty HCPs from a real territory, anonymized, with tier, specialty and address. Ask the vendor to load them before the call. Then run the test yourself and don’t let the vendor’s person drive.

Plan a week first. Pick a rep, ask the system for Monday to Friday by tier and distance, and watch whether that comes from the CRM or from someone’s head. Then log a visit on one of your doctors and time it: product detailed, material shown, outcome, next visit date. Over a minute and reps will stop doing it by the second month. Do it once with the phone in airplane mode, too, because hospital basements and rural practices often have no signal, and a visit that can’t be saved offline is a visit that gets typed up from memory on Friday.

Then record consent on that HCP and try to send a marketing email to a different one who has no consent recorded. If the email goes out anyway, the system stores consent without enforcing it. Switch to the manager’s seat and ask for one territory: target HCPs visited this month against the plan, by tier, and the tier-A doctors nobody has seen in thirty days. Last, edit the note on the visit you just logged and ask to see the previous version with a timestamp. If it’s gone, you have your Part 11 conversation already.

Pass all five and the system does the pharma job, whatever class it belongs to. A fail on the visit log or on the manager’s territory view rules it out, even with life sciences in the product name.

## Numbers for the Monday review

Visits per rep per week is the number every pharma team already has, and it tells a manager the least. Review a short set instead, per rep, because a team average hides teh rep whose visits all have empty notes.

Coverage: target HCPs visited this month against target HCPs in the plan, by tier. Frequency against plan for tier A only, the rest will follow. Visits with no note and visits with no next date, where the only acceptable number is zero. Days since last visit for every tier-A doctor, sorted descending, because the top of that list is where the quarter gets lost. And consent coverage of the HCP list the marketing team wants to email.

Most of these are the questions a sales manager asks of a deal pipeline, with “visit” in place of “activity” and “HCP” in place of “account”. A visit with no note and no next date is the same disease as a deal with no next activity. If your team runs the pharma layer on a general CRM, that is exactly what the free SalesBond CRM audit looks at. It reads the last 30 days of the connected CRM and sends a PDF report with the fixes sorted by the money at risk. SalesBond works with HubSpot, Zoho CRM, Pipedrive, Salesforce, Microsoft Dynamics 365 and the other CRMs on its integration list, so you can [Check your CRM with SalesBond](https://salesbond.app/) and read the activity findings first, or [start with SalesBond](https://app.salesbond.app/auth/signup) and see how many of last month’s visits have no note and no next date. The manual version is in [CRM audit: what a 30-day check finds](https://salesbond.app/blog/crm-audit-what-a-30-day-check-finds/).

## FAQ

**What is a pharmaceutical CRM?** A CRM that holds the healthcare professional as the customer, the visit as the main activity, and consent and approved materials on the same record, with a territory view for the manager. Most also track the organizations doctors work in (HCOs, such as hospitals and clinics) and key opinion leaders (KOLs) separately from the general HCP list. Industry platforms ship that model; a general CRM is configured into it with custom fields and activity types.

**Which company is best for a pharma CRM?** There’s no single answer, and this article doesn’t rank. A large field force with samples and promotional-content rules usually ends up on an industry platform such as Veeva Vault CRM or Salesforce Life Sciences Cloud. A small team selling to pharmacies, wholesalers or clinics without samples is usually well served by a configured general CRM. The five-step demo above decides it for your team faster than any list.

**What is 21 CFR Part 11 in pharma?** It is the FDA regulation on electronic records and electronic signatures. FDA’s 2003 guidance says the agency interprets its scope narrowly and that the underlying predicate rules still decide which records must be kept ( [FDA guidance](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application)). Whether your CRM records fall under it is a question for your compliance team, whatever it says in the vendor’s brochure.

**What are the components of a CRM for a pharma team?** Lists of “seven components” differ by who writes them. The pieces a pharma team actually buys are the HCP record with tier and specialty, the visit plan, the visit log, consent, approved materials, the territory, and the manager’s coverage report. On the demo, ask to see the first five on one HCP record, then ask how that record rolls up into the territory and the coverage report.
